Veracyte Inc. Stock
Your prediction
Veracyte Inc. Stock
The price for the Veracyte Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.220 (-0.640%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Veracyte Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Veracyte Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Veracyte Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Veracyte Inc. | -0.640% | 16.821% | 13.669% | 18.797% | -12.222% | 56.436% | -10.227% |
| Heron Therapeutics Inc. | -2.990% | 3.235% | 54.512% | -50.424% | -5.476% | -47.871% | -92.305% |
| Evolus Inc | 0.110% | 15.568% | 50.757% | -48.757% | -3.156% | -30.553% | -28.190% |
| Sangamo Therapeutics Inc. | 50.930% | 35.092% | -41.262% | -71.434% | -56.089% | -87.325% | -98.221% |
News
Why Veracyte Stock Is Skyrocketing Higher This Week
Shares of leading diagnostics platform and cancer-detecting genomic test provider Veracyte (NASDAQ: VCYT) are up 23% over the last week as of market close Thursday, after the company reported
